Table: Pharmarise Holdings -2019/20 group results

Pharmarise Holdings

15/07/2020 11:00

Jul 15 (Reuters)- 
          Pharmarise Holdings Corp 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                May 31, 2020    May 31, 2019   May 31, 2021     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             51.03           51.73          54.04        26.24    
                 (-1.3 pct)      (-5.2 pct)     (+5.9 pct)    (+1.9 pct) 
  Operating        987 mln         640 mln          1.17       411 mln   
                 (+54.2 pct)     (-45.7 pct)    (+18.2 pct)  (-21.1 pct) 
  Recurring        976 mln         590 mln          1.11       383 mln   
                 (+65.2 pct)     (-45.9 pct)    (+14.0 pct)  (-26.7 pct) 
  Net
  Net              526 mln         23 mln         376 mln       70 mln   
                                                (-28.6 pct)  (-88.2 pct) 
  EPS             55.72 yen       2.55 yen       40.51 yen     7.54 yen  
  EPS Diluted     42.31 yen       2.24 yen                               
  Ann Div         14.00 yen       14.00 yen      14.00 yen               
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div         14.00 yen       14.00 yen      14.00 yen               
  
  NOTE - Pharmarise Holdings Corp.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T